OC-0647 Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project

During the past decades, cancer treatment has been improved in a technically and medically manner.Nonetheless, the 5-year overall survival rate for head and neck squamous cell carcinoma (HNSCC) is still at about 50%.Currently, most patients with functionally inoperable HNSCC are treated with primary radiochemotherapy (RCTx).In contrast to radiotherapy alone, clinical trials showed that patients who received RCTx benefit in terms of increased...